Program to improve care in complex chronic disease

改善复杂慢性疾病护理的计划

基本信息

  • 批准号:
    8190211
  • 负责人:
  • 金额:
    $ 13.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-02 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The purpose of this 5-year award is to build upon the unique multidisciplinary training of the principle investigator in patient-oriented research pertaining to translational research in complex chronic disease, and strengthen her ability to guide the next generation of scholars. Specifically, with this award the investigator will: (1) Expand her content expertise pertaining to mobile- and web-based applications useful for translational research. (2) Develop and pilot test a new web-supported lifestyle management intervention in those with chronic kidney disease. (3) Serve as a mentor for trainees and junior faculty members pursuing patient-oriented research activities and careers pertaining to translational research in those with multimorbidity. (4) Institutionalize her program of research by developing a P30 application to support a Center on Translational Research in Multimorbidity. PUBLIC HEALTH RELEVANCE: The number of people with chronic illness is growing and projected to reach 171 million by the year 2030, and almost 1/2 of those with a chronic disease have multiple chronic conditions. However, the literature on self-management has been derived mainly from empirical work in prevention or populations with uncomplicated disease and employ interventions that target a single behavior. This application is designed to further the candidate's patient-oriented translational research in multimorbidity. The award will provide the applicant with sufficient protected time to accomplish the following aims: (1) mentor the next generation of researchers, (2) engage in a mid-career shift to incorporate web-based interventions into her research, (3) develop and implement a pilot study using a web-based intervention in chronic kidney disease patients, and (4) develop a P30 application to institutionalize her research program with a Center for Translational Research in Multimorbidity.
描述(由申请人提供):这个为期5年的奖项的目的是建立在与复杂慢性病转化研究有关的以患者为导向的研究的主要研究者的独特多学科培训的基础上,并加强她指导下一代学者的能力。具体而言,通过该奖项,研究者将:(1)扩大她在移动的和基于网络的应用程序对翻译研究有用的内容专业知识。(2)在慢性肾脏疾病患者中开发和试点测试一种新的网络支持的生活方式管理干预。(3)担任学员和初级教员的导师,从事以患者为导向的研究活动和与多Mortocell患者的转化研究有关的职业。(4)通过开发一个P30应用程序来支持多学科转化研究中心,使她的研究计划制度化。 公共卫生相关性:慢性病患者的人数正在增加,预计到2030年将达到1.71亿,近1/2的慢性病患者患有多种慢性病。然而,关于自我管理的文献主要来自预防或患有简单疾病的人群的经验性工作,并采用针对单一行为的干预措施。这个应用程序的目的是进一步候选人的病人为导向的翻译研究多morphine。该奖项将为申请人提供足够的保护时间,以实现以下目标:(1)指导下一代研究人员,(2)从事职业生涯中期转变,将基于网络的干预纳入其研究,(3)在慢性肾病患者中使用基于网络的干预开发并实施试点研究,和(4)开发一个P30应用程序,使她的研究计划制度化,并在多个国家的翻译研究中心。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mary A Sevick其他文献

COST AND BENEFITS OF PROPHYLAXIS OF VERY LOW BIRTH WEIGHT (VLBW) INFANTS WITH RESPIRATORY SYNCYTIAL VIRUS (RSV) IMMUNE GLOBULIN † 1229
预防极低出生体重(VLBW)婴儿呼吸道合胞病毒(RSV)免疫球蛋白的成本和效益 † 1229
  • DOI:
    10.1203/00006450-199704001-01248
  • 发表时间:
    1997-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    T Michael O'Shea;Mary A Sevick;Laurence B Givner
  • 通讯作者:
    Laurence B Givner

Mary A Sevick的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mary A Sevick', 18)}}的其他基金

Behavioral Management of Phosphorus in Hemodialysis
血液透析中磷的行为管理
  • 批准号:
    9334846
  • 财政年份:
    2016
  • 资助金额:
    $ 13.4万
  • 项目类别:
Lifestyle Management of CKD in Obese Diabetic Patients
肥胖糖尿病患者 CKD 的生活方式管理
  • 批准号:
    9323387
  • 财政年份:
    2014
  • 资助金额:
    $ 13.4万
  • 项目类别:
Lifestyle Management of CKD in Obese Diabetic Patients
肥胖糖尿病患者 CKD 的生活方式管理
  • 批准号:
    8818276
  • 财政年份:
    2014
  • 资助金额:
    $ 13.4万
  • 项目类别:
Lifestyle Management of CKD in Obese Diabetic Patients
肥胖糖尿病患者 CKD 的生活方式管理
  • 批准号:
    8930137
  • 财政年份:
    2014
  • 资助金额:
    $ 13.4万
  • 项目类别:
Program to Improve Care in Complex Chronic Disease
改善复杂慢性疾病护理的计划
  • 批准号:
    8731161
  • 财政年份:
    2011
  • 资助金额:
    $ 13.4万
  • 项目类别:
Program to improve care in complex chronic disease
改善复杂慢性疾病护理的计划
  • 批准号:
    8327697
  • 财政年份:
    2011
  • 资助金额:
    $ 13.4万
  • 项目类别:
Program to Improve Care in Complex Chronic Disease
改善复杂慢性疾病护理的计划
  • 批准号:
    8736010
  • 财政年份:
    2011
  • 资助金额:
    $ 13.4万
  • 项目类别:
Program to Improve Care in Complex Chronic Disease
改善复杂慢性疾病护理的计划
  • 批准号:
    8925924
  • 财政年份:
    2011
  • 资助金额:
    $ 13.4万
  • 项目类别:
Intervention to Reduce Dietary Sodium in Hemodialysis
血液透析中减少膳食钠摄入的干预措施
  • 批准号:
    7874682
  • 财政年份:
    2008
  • 资助金额:
    $ 13.4万
  • 项目类别:
Intervention to Reduce Dietary Sodium in Hemodialysis
血液透析中减少膳食钠摄入的干预措施
  • 批准号:
    7516503
  • 财政年份:
    2008
  • 资助金额:
    $ 13.4万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 13.4万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 13.4万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 13.4万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 13.4万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 13.4万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 13.4万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 13.4万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 13.4万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 13.4万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 13.4万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了